{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:28:37Z","timestamp":1790810917032,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T00:00:00Z","timestamp":1659830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T00:00:00Z","timestamp":1659830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Finnish Cancer Foundation"},{"name":"University of Oulu including Oulu University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gastric cancer is the fourth leading cause of cancer-related deaths globally. There is a paucity of national studies examining gastric cancer mortality in relation to treatment status. This study evaluated the survival trends in gastric adenocarcinoma and all gastric cancers stratified by treatment in Finland during 1987\u20132016.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This population-based, nationwide, retrospective cohort study included all gastric cancer patients registered in the Finnish Cancer Registry and Patient Registry. The survival rates were calculated for 1, 3, and 5\u00a0years, stratified by treatment. Prognostic factors were determined using Cox regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 18,713 non-cardia gastric adenocarcinoma, and 3617 cardia adenocarcinoma patients were included. Surgical treatment decreased for non-cardia adenocarcinoma and remained constant for cardia adenocarcinoma. In non-cardia adenocarcinoma, the 5-year survival declined from 17% to 16% from 1987\u20131991 to 2012\u20132016. In surgically treated patients, survival increased from 29% to 38%, while an increase from 4% to 7% in those undergoing chemotherapy and decrease from 6% to 3% in those not receiving any treatment were observed. In cardia adenocarcinoma, the 5-year survival increased from 10% to 18% in all patients, 16% to 40% in surgical patients, 0% to 5% in patients receiving chemotherapy, and from 5% to 9% in patients receiving no treatment. Earlier calendar periods, older age, male sex, and higher comorbidity were risk factors for poor prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Gastric non-cardia adenocarcinoma survival declined, limited to advanced stage patients not receiving any treatment. Gastric cardia cancer survival seems to have improved over time in Finland.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Mini abstract<\/jats:title>\n                <jats:p>This study evaluated survival trends of gastric cancer in Finland during 1987\u20132016 and established that the 5-year survival is declining in non-cardia adenocarcinoma but improving in all gastric cancers.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10120-022-01326-5","type":"journal-article","created":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T09:02:17Z","timestamp":1659862937000},"page":"989-1001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8514-1974","authenticated-orcid":false,"given":"Urgena","family":"Maharjan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonas H.","family":"Kauppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,7]]},"reference":[{"issue":"3","key":"1326_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA A Cancer J Clin"},{"issue":"3","key":"1326_CR2","first-page":"251","volume":"3","author":"B Hu","year":"2012","unstructured":"Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3):251\u201361.","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"1326_CR3","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2014-308915","volume":"64","author":"A Colquhoun","year":"2015","unstructured":"Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64(12):1881.","journal-title":"Gut"},{"issue":"suppl 5","key":"1326_CR4","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38\u201349.","journal-title":"Ann Oncol"},{"issue":"7","key":"1326_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11894-016-0506-0","volume":"18","author":"CM den Hoed","year":"2016","unstructured":"den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18(7):34.","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"1326_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","volume":"12","author":"KD Crew","year":"2006","unstructured":"Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354\u201362.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"1326_CR7","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.7150\/jca.51433","volume":"12","author":"L Lv","year":"2021","unstructured":"Lv L, Liang X, Wu D, Wang F, Zhang Y, Cang H, et al. Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer. J Cancer. 2021;12(8):2385\u201394.","journal-title":"J Cancer"},{"issue":"11","key":"1326_CR8","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1007\/s10620-010-1351-x","volume":"55","author":"J Bornschein","year":"2010","unstructured":"Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner PH. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci. 2010;55(11):3124\u201331.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"1326_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jamcollsurg.2007.06.306","volume":"206","author":"H Maeda","year":"2008","unstructured":"Maeda H, Okabayashi T, Nishimori I, Sugimoto T, Namikawa T, Dabanaka K, et al. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg. 2008;206(2):306\u201310.","journal-title":"J Am Coll Surg"},{"issue":"15","key":"1326_CR10","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.ejca.2015.07.026","volume":"51","author":"LA Anderson","year":"2015","unstructured":"Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999\u20132007: results from EUROCARE-5. Eur J Cancer. 2015;51(15):2144\u201357.","journal-title":"Eur J Cancer"},{"issue":"6","key":"1326_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.ejca.2008.11.029","volume":"45","author":"A Verdecchia","year":"2009","unstructured":"Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer. 2009;45(6):1042\u201366.","journal-title":"Eur J Cancer"},{"issue":"11","key":"1326_CR12","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/jjco\/hyt166","volume":"43","author":"T Matsuda","year":"2013","unstructured":"Matsuda T, Saika K. The 5-year relative survival rate of stomach cancer in the USA, Europe and Japan. Jpn J Clin Oncol. 2013;43(11):1157\u20138.","journal-title":"Jpn J Clin Oncol"},{"issue":"9","key":"1326_CR13","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1245\/s10434-018-6627-y","volume":"25","author":"J Asplund","year":"2018","unstructured":"Asplund J, Kauppila JH, Mattsson F, Lagergren J. Survival trends in gastric adenocarcinoma: a population-based study in Sweden. Ann Surg Oncol. 2018;25(9):2693\u2013702.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1326_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039574","volume":"10","author":"JH Kauppila","year":"2020","unstructured":"Kauppila JH, Ohtonen P, Rantanen T, Tyrv\u00e4inen T, Toikkanen V, P\u00e4\u00e4aho M, et al. Cohort profile: gastric cancer in the population-based, Finnish National Esophago-Gastric Cancer Cohort (FINEGO) Study. BMJ Open. 2020;10(10): e039574.","journal-title":"BMJ Open"},{"issue":"1","key":"1326_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024094","volume":"9","author":"JH Kauppila","year":"2019","unstructured":"Kauppila JH, Ohtonen P, Karttunen TJ, Kokkola A, Laine S, Rantanen T, et al. Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland. BMJ Open. 2019;9(1): e024094.","journal-title":"BMJ Open"},{"key":"1326_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2017.02.017","volume":"77","author":"MK Leinonen","year":"2017","unstructured":"Leinonen MK, Miettinen J, Heikkinen S, Pitk\u00e4niemi J, Malila N. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31\u20139.","journal-title":"Eur J Cancer"},{"issue":"6","key":"1326_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1403494812456637","volume":"40","author":"R Sund","year":"2012","unstructured":"Sund R. Quality of the Finnish hospital discharge register: a systematic review. Scand J Public Health. 2012;40(6):505\u201315.","journal-title":"Scand J Public Health"},{"key":"1326_CR18","unstructured":"Official Statistics of Finland (OSF): Causes of death [e-publication]. ISSN=1799-5078. 2018, Quality Description: Causes of death 2018 . Helsinki: Statistics Finland [referred: 16.9.2021]. Access method: http:\/\/www.stat.fi\/til\/ksyyt\/2018\/ksyyt_2018_2019-12-16_laa_001_en.html"},{"issue":"4","key":"1326_CR19","doi-asserted-by":"publisher","first-page":"e056320","DOI":"10.1136\/bmjopen-2021-056320","volume":"12","author":"U Maharjan","year":"2022","unstructured":"Maharjan U, Kauppila JH. Gastric cancer completeness in Finnish Cancer Registry and Finnish Patient Registry: a population-based nationwide retrospective cohort study. BMJ Open. 2022;12(4):e056320 (Published 2022 Apr 19).","journal-title":"BMJ Open"},{"issue":"6","key":"1326_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.ejca.2010.02.013","volume":"46","author":"AE Dassen","year":"2010","unstructured":"Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in The Netherlands. Eur J Cancer. 2010;46(6):1101\u201310.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1326_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.amsu.2014.03.003","volume":"3","author":"JA Young","year":"2014","unstructured":"Young JA, Shimi SM, Kerr L, McPhillips G, Thompson AM. Reduction in gastric cancer surgical mortality over 10 years: an adverse events analysis. Ann Med Surg (Lond). 2014;3(2):26\u201330.","journal-title":"Ann Med Surg (Lond)"},{"issue":"12","key":"1326_CR22","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1007\/s11605-017-3531-x","volume":"21","author":"SD Nelen","year":"2017","unstructured":"Nelen SD, Heuthorst L, Verhoeven RHA, Polat F, Kruyt PM, Reijnders K, et al. Impact of centralizing gastric cancer surgery on treatment, morbidity, and mortality. J Gastrointest Surg. 2017;21(12):2000\u20138.","journal-title":"J Gastrointest Surg"},{"issue":"Suppl 24","key":"1326_CR23","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1002\/cncr.30881","volume":"123","author":"MA Jim","year":"2017","unstructured":"Jim MA, Pinheiro PS, Carreira H, Espey DK, Wiggins CL, Weir HK. Stomach cancer survival in the United States by race and stage (2001\u20132009): findings from the CONCORD-2 study. Cancer. 2017;123(Suppl 24):4994\u20135013.","journal-title":"Cancer"},{"issue":"2","key":"1326_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4143\/crt.2020.206","volume":"52","author":"S Hong","year":"2020","unstructured":"Hong S, Won Y, Park YR, Jung K, Kong H, Lee ES, et al. Cancer Statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat. 2020;52(2):335\u201350.","journal-title":"Cancer Res Treat"},{"issue":"10","key":"1326_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100812","volume":"13","author":"H Zhang","year":"2020","unstructured":"Zhang H, Liu Q. Prognostic indicators for gastrointestinal stromal tumors: a review. Transl Oncol. 2020;13(10): 100812.","journal-title":"Transl Oncol"},{"issue":"3","key":"1326_CR26","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1055\/s-0041-1731427","volume":"7","author":"N Kargwal","year":"2021","unstructured":"Kargwal N, Panda V, Jha A, Singh CB. Gastric neuroendocrine tumor. Surg J (N Y). 2021;7(3):e142\u20136.","journal-title":"Surg J (N Y)"},{"issue":"988","key":"1326_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1259\/bjr\/98067945","volume":"83","author":"B Lumbreras","year":"2010","unstructured":"Lumbreras B, Donat L, Hern\u00e1ndez-Aguado I. Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol. 2010;83(988):276\u201389.","journal-title":"Br J Radiol"},{"issue":"1","key":"1326_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033323","volume":"10","author":"L Lou","year":"2020","unstructured":"Lou L, Wang L, Zhang Y, Chen G, Lin L, Jin X, et al. Sex difference in incidence of gastric cancer: an international comparative study based on the Global Burden of Disease Study 2017. BMJ Open. 2020;10(1): e033323.","journal-title":"BMJ Open"},{"key":"1326_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ypmed.2016.12.004","volume":"96","author":"A Blanc-Lapierre","year":"2017","unstructured":"Blanc-Lapierre A, Rousseau M, Weiss D, El-Zein M, Siemiatycki J, Parent M. Lifetime report of perceived stress at work and cancer among men: a case\u2013control study in Montreal, Canada. Prev Med. 2017;96:28\u201335.","journal-title":"Prev Med"},{"issue":"3","key":"1326_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10654-011-9647-5","volume":"27","author":"G Edgren","year":"2012","unstructured":"Edgren G, Liang L, Adami HO, Chang ET. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012;27(3):187\u201396.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1326_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/10810730701807076","volume":"13","author":"A McQueen","year":"2008","unstructured":"McQueen A, Vernon SW, Meissner HI, Rakowski W. Risk perceptions and worry about cancer: does gender make a difference? J Health Commun. 2008;13(1):56\u201379.","journal-title":"J Health Commun"},{"issue":"1","key":"1326_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/1055-9965.EPI-11-0834","volume":"21","author":"MC Camargo","year":"2012","unstructured":"Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012;21(1):20.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"16","key":"1326_CR33","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.ejca.2008.07.031","volume":"44","author":"E Chandanos","year":"2008","unstructured":"Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008;44(16):2397\u2013403.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1326_CR34","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1158\/1940-6207.CAPR-11-0219","volume":"4","author":"A Sheh","year":"2011","unstructured":"Sheh A, Ge Z, Parry NMA, Muthupalani S, Rager JE, Raczynski AR, et al. 17\u03b2-Estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice. Cancer Prev Res (Phila). 2011;4(9):1426.","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-022-01326-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-022-01326-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-022-01326-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T14:29:01Z","timestamp":1666448941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-022-01326-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,7]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1007\/s10120-022-01326-5","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,7]]},"assertion":[{"value":"5 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical standards approved by the ethical committee in Northern Ostrobothnia (EETMK 115\/2016), The National Institute for Health and Welfare (THL\/169\/5.05.00), Statistics Finland (TK-53-1478-17), the Office of the Data Protection Ombudsman (Dnro 506\/402\/17), Finland and with the Helsinki Declaration. Individual informed consent from patients was not required, as obtaining the informed consent was waived by Finnish law.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}